affypharma.com

We performed a comprehensive analysis of affypharma.com on 2026-06-28. The website returned an HTTP 200 status code with a server response time of 14976ms. The page is served over HTTP/2 protocol with Gzip compression enabled, achieving approximately 60.0% size reduction. The total page weight is 51 KB, and the site is served behind a CDN (Content Delivery Network). Warning: The website does not have a valid SSL certificate. Visitors may see security warnings in their browser, and data transmitted to and from this website is not encrypted. The security headers analysis reveals a score of 30/100 (below average). The following security headers are properly configured: X-Content-Type-Options and Referrer-Policy. However, the site is missing Content-Security-Policy, Strict-Transport-Security (HSTS), X-Frame-Options, and Permissions-Policy, which could expose the site and its users to cross-site scripting (XSS), clickjacking, and other web-based attacks. Our technology detection scan identified 4 technologies across 4 categories powering affypharma.com. The detected stack includes Bootstrap, Cloudflare, Google Fonts, and Font Awesome. Based on our comprehensive analysis of domain age, SSL configuration, email authentication, security headers, and blacklist status, affypharma.com receives an overall trust score of 61/100, classified as "Likely Safe".

After conducting a thorough safety and legitimacy analysis, affypharma.com receives a trust score of 61/100, which places it in the "Likely Safe" category. This score is calculated by evaluating multiple factors including SSL certificate validity, domain registration history, email authentication protocols, security header configuration, and blacklist status across major threat intelligence databases. The analysis identified several positive trust signals: a valid HTTPS connection protecting data in transit and SPF (Sender Policy Framework) email authentication preventing email spoofing. Areas of concern include: the absence of a Content-Security-Policy header, which leaves the site more vulnerable to cross-site scripting (XSS) attacks, no X-Frame-Options header, which could allow the site to be embedded in malicious iframes (clickjacking), the domain's WHOIS information is hidden behind a privacy service, making it harder to verify the owner's identity, and DNSSEC is not enabled, leaving DNS queries vulnerable to spoofing attacks. While these issues don't necessarily indicate malicious intent, they represent areas where the website's security posture could be improved. We checked affypharma.com against 8 major blacklist databases including Google Safe Browsing, Phishtank, Urlhaus, Openphish, Dnsfilter, Spamhaus Dbl, Surbl, and Virustotal. The domain passed all 8 checks with a clean status, meaning it has not been flagged for phishing, malware distribution, spam, or other malicious activities by any of the tested threat intelligence providers.

Our technology detection engine scanned affypharma.com and identified 4 distinct technologies across 4 categories. This analysis is performed by examining HTTP response headers, HTML source code patterns, JavaScript library fingerprints, CSS framework signatures, and DNS records. CSS Framework: Bootstrap — provides the styling and responsive layout system for affypharma.com. CDN: Cloudflare — accelerates content delivery by caching assets at edge locations worldwide for affypharma.com. Fonts: Google Fonts — delivers web fonts for typography for affypharma.com. Icon Set: Font Awesome — provides additional functionality for affypharma.com.

affypharma.com delivers its homepage in 14976ms (server response time), which is considered slow by industry standards. The total page weight is 51 KB, and we detected 119 resource requests loading assets from 5 third-party domains. A high number of third-party domains can significantly impact page load time due to additional DNS lookups and TLS handshakes required for each domain. The website uses Gzip compression for text-based assets, achieving an estimated 60.0% reduction in transfer size. This reduces bandwidth usage and improves page load times, especially for visitors on slower connections. Asset minification status: 4 out of 8 CSS files and 6 out of 10 JavaScript files are minified. Minifying the remaining 8 unminified file(s) could further reduce page weight by 10-30% for those assets. Minification is a best practice that reduces download sizes without affecting functionality. The site is served through a Content Delivery Network (CDN), which caches static assets at edge servers around the world. This means visitors from different geographic regions receive content from the nearest edge server, significantly reducing latency. CDN usage is particularly important for websites with a global audience, as it can reduce page load times by 40-60% for distant visitors. From an environmental perspective, each page view of affypharma.com produces approximately 0.02g of CO₂, earning a carbon rating of A. This places the website among the cleanest on the web, demonstrating efficient use of server resources and optimized content delivery. For reference, the average web page produces about 0.5g of CO₂ per page view. The page weight of 51 KB is the primary factor in this calculation. Core Web Vitals data from the Chrome User Experience Report (CrUX) is not available for affypharma.com. This typically means the site doesn't have enough real-world Chrome user traffic to generate statistically significant field data, or the domain is not included in the CrUX dataset. Core Web Vitals (LCP, INP, CLS) are important Google ranking factors that measure real user experience.

affypharma.com resolves to the IPv4 address 172.67.131.231 and also supports IPv6 (2606:4700:3030::6815:c0d), demonstrating modern network infrastructure readiness. The domain has 2 A record(s) configured. The domain name system is managed by 2 name servers: moura.ns.cloudflare.com and priscilla.ns.cloudflare.com. Having 2 name servers provides good redundancy — if one fails, the others can continue serving DNS queries. The choice of name servers often indicates the DNS hosting provider or CDN service being used. Email for affypharma.com is handled by Google Workspace with 5 MX records configured: aspmx.l.google.com, alt1.aspmx.l.google.com, and alt2.aspmx.l.google.com and 2 more. Multiple MX records provide failover redundancy — if the primary mail server is unavailable, email will be routed to the next available server. SPF (Sender Policy Framework) is configured, which specifies which mail servers are authorized to send email on behalf of this domain. This helps prevent email spoofing and improves email deliverability. DMARC is not configured, leaving the domain vulnerable to email spoofing and phishing attacks that impersonate this domain. DKIM was not detected. Without DKIM, recipients cannot cryptographically verify that emails claiming to be from this domain are authentic. DNSSEC is not enabled for affypharma.com. While not critical for most websites, DNSSEC adds an important security layer by ensuring DNS responses haven't been tampered with during transit. Enabling DNSSEC is recommended for domains handling sensitive data or financial transactions. Our subdomain enumeration scan discovered 1 active subdomains for affypharma.com: www.affypharma.com. Active subdomains can reveal the organization's infrastructure, including development environments, API endpoints, and third-party service integrations.

The homepage of affypharma.com contains 1,498 words of visible text content. This is a substantial amount of content that provides good opportunities for search engine indexing. The page is structured with 9 H2 headings, 27 H3 headings, 13 H4 headings, 6 H5, and 0 H6 headings. The page includes 32 images. 19 images (59%) are missing alt text attributes, which is a significant concern for both accessibility and SEO. Screen readers rely on alt text to describe images to visually impaired users, and search engines use alt text to understand image content. Only 41% of images have proper alt text — we recommend adding descriptive alt attributes to all images. The link structure consists of 61 internal links pointing to other pages on the same domain and 1 external link pointing to third-party websites. There are 10 external JavaScript files, 8 CSS stylesheets, and 1 iframes on the page. The site implements the following web standards and features: XML Sitemap (helps search engines discover all pages) and Progressive Web App (PWA) manifest (enabling app-like installation). Notable missing features: robots.txt and Schema.org structured data. Adding these could improve search engine discoverability and rich result eligibility.

The title tag for affypharma.com is too long at 72 characters: "Affy Pharma Pvt Ltd | GMP Certified Pharmaceutical Manufacturer in India". At 72 characters, the title will likely be truncated in Google search results (recommended: 50-60 characters). Consider shortening it while keeping the most important keywords at the beginning. The meta description is 214 characters (slightly long): "Affy Pharma Pvt Ltd is a GMP & ISO certified pharmaceutical manufacturing company in India, specializing in tablets, cap...". Google typically displays up to 155-160 characters of the meta description in search results. A compelling meta description with a clear call-to-action can significantly improve click-through rates from search results. The canonical url is correctly set to https://www.affypharma.com/, preventing duplicate content issues, the page language is declared as en, the meta robots directive is set to index, follow, and a favicon is configured. No Open Graph tags are configured. When someone shares a link to affypharma.com on social media, the platform will have to guess the title, description, and image — often producing unattractive or inaccurate previews. Adding OG tags is essential for social media marketing. The meta keywords tag contains 10 terms including Affy Pharma Pvt Ltd, pharmaceutical manufacturer in India, GMP certified pharma company, contract manufacturing pharma, and tablet manufacturing company. Note: Google has officially confirmed that it does not use the meta keywords tag as a ranking signal. However, some other search engines (Bing, Yandex) may still reference it.